Status | Study |
Completed |
Study Name: Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma Condition: Adenomatous Polyp Recurrent Colon Cancer Recurrent Rectal Date: 2008-09-17 Interventions: Drug: erlotinib hydrochloride |
Completed |
Study Name: Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial Condition: Colorectal Neoplasms Date: 2008-02-15 Interventions: Procedure: Surgical removal of ACF |
Completed |
Study Name: Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci) Condition: Healthy, no Evidence of Disease Tobacco Use Disorder Date: 2006-08-16 Interventions: Other: laboratory biomarker analysis |
Terminated |
Study Name: The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon Condition: Aberrant Crypt Foci Date: 2005-09-13 Interventions: Drug: sulindac Sulindac 150 mg |